The Bonnie J. Addario Lung Cancer Foundation and the International Association for the Study of Lung Cancer announced the second annual joint fellowship award to support research on the early detection of lung cancer.
SU2C is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research said. Funded by a grant Bristol-Myers Squibb Co. a total of 10 Innovative Research Grants will be available, each up to $750,000, over three years. The IRG... […]
SU2C and Genentech announced a Catalyst collaboration aimed at accelerating the development of new cancer treatments and combination therapies by providing funding and access to a dozen of the company's medicines.
THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE is accepting applications for its Prize for Young Investigators in Cancer Research.
The Fiscal Year 2016 Defense Appropriations Act provides $120 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research to accelerate progress toward ending breast cancer.
Applications are being accepted for the ACMG Foundation/Shire Laboratory Geneticist Fellowship Awards and Clinical Genetics Residency Program. The program will facilitate 10 one-to-two-year training awards for medical geneticists over the next three years, after a $1.65 million commitment from Shire.
Stand Up To Cancer announced a request for proposals under SU2C Catalyst, a program supporting clinical trials and translational research.
The Department of Defense Lung Cancer Research Program is accepting preapplications and letters of intent for concept award grant, worth up to $100,000 for one year, for direct costs not related directly to clinical trials.
CureSearch for Children's Cancer began taking applications for its International Grand Challenge Awards addressing three challenges in pediatric cancer treatment. The awards will be worth between $2 million and $3 million.
FDA will provide $2 million in two to five research grants for the study of the natural history of rare diseases. The objective of the grants is to expedite the development of products for these conditions.
